Announcements Trials
Browse Landscape

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 22Observational 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 16Neoplasms 3Neoplasm Metastasis 2Multiple Endocrine Neoplasia Type 1 1Hormone Receptor Positive Advanced Breast Cancer 1HR+ Breast Cancer 1HER2-positive Metastatic Breast Cancer 1Breast Neoplasm Female 1Breast Diseases 1Breast Cancer Organoids 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Neoplasms × Fulvestrant × Clear all
NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

The Affiliated Hospital of Qingdao University

Not yet recruiting
200 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms

NCT04524728 2020-08-24

Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy

Istituti Clinici Scientifici Maugeri SpA

Completed
191 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT01399086 2012-03-13

Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

Hellenic Oncology Research Group

Completed
140 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡